ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences.SAN DIEGO -- ACADIA Acadia (əkā`dēə), Fr. Acadie, region and former French colony, E Canada, encompassing modern Nova Scotia but also New Brunswick, Prince Edward Island, and coastal areas of E Maine. After an abortive 1604 settlement of St. Pharmaceuticals Inc. (Nasdaq: ACAD ACAD Academy ACAD Academic ACAD AutoCAD (design/drafting development software by Autodesk) ACAD Acadia National Park (US National Park Service) ACAD Atherosclerotic Coronary Artery Disease ), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders Nervous system disorders A satisfactory classification of diseases of the nervous system should include not only the type of reaction (congenital malformation, infection, trauma, neoplasm, vascular diseases, and degenerative, metabolic, toxic, or deficiency , today announced that it will present at the following investor conferences: * The Rodman & Renshaw 8th Annual Healthcare Conference on Wednesday, November 8, 2006 at 11:20 a.m. Eastern Time at The New York Palace
New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . * The San Diego BIOCOM Investor Conference on Wednesday, November 15, 2006 at 9:20 a.m. Pacific Time at the San Diego Marriott Del Mar in San Diego. * The JMP Securities Sector Focus Conference on Thursday, November 16, 2006 at 10:00 a.m. Eastern Time at the Four Seasons Hotel in Boston. * The Piper Jaffray Healthcare Conference on Wednesday, November 29, 2006 at 10:00 a.m. Eastern Time at the Pierre Hotel in New York City. Live webcasts of these presentations will be accessible on the company's website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website for two weeks following the presentation. About ACADIA Pharmaceuticals ACADIA is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACADIA currently has five Phase II-stage clinical programs as well as a portfolio of preclinical and discovery assets directed at large unmet medical needs, including schizophrenia, Parkinson's disease, sleep maintenance insomnia, and neuropathic pain. All of the drug candidates in ACADIA's product pipeline emanate from discoveries made using its proprietary drug discovery platform. ACADIA's corporate headquarters is located in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation). San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951. and it maintains research and development operations in both San Diego and MalmE, Sweden. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion